The high cost of prescription drugs is a significant concern for everyone, and controlling these costs is a top priority. However, the biggest question facing Medicare and State Prescription Drug Affordability Boards (PDAB) is how to achieve this goal. Oregon is just beginning to address this issue and needs to hear from patients on how to engage in a meaningful way.
Sara Traigle van Geertruyden, Executive Director of Partnership to Improve Patient Care, along with advocates from states that are further ahead than Oregon, will present the lessons they have learned about patient engagement.
Негізгі бет Engaging Patients in Prescription Drug Affordability Board Processes: Lessons Learned
Пікірлер